1-4 of 4
Susan M. Edgerton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor–Positive Breast Cancers

Reema S. Wahdan-Alaswad, Susan M. Edgerton, Hiba Salem, Hyun Min Kim, Aik Choon Tan, Jessica Finlay-Schultz, Elizabeth A. Wellberg, Carol A. Sartorius, Britta M. Jacobsen, Bryan R. Haugen, Bolin Liu, Ann D. Thor
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (2): 585–597.
DOI: https://doi.org/10.1158/1078-0432.CCR-20-2647
Published: 19 January 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract B20: Role of ErbB3 in tumorigenesis and drug resistance in ErbB2-driven breast cancer

Hui Lyu, Jingcao Huang, Susan M. Edgerton, Ann D. Thor, Bolin Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): B20.
DOI: https://doi.org/10.1158/1557-3265.PMS14-B20
Published: 13 February 2015
View article
Journal Articles

Gelsolin as a Negative Prognostic Factor and Effector of Motility in erbB-2-positive Epidermal Growth Factor Receptor-positive Breast Cancers

Ann D. Thor, Susan M. Edgerton, Shuqing Liu, Dan H. Moore, II, David J. Kwiatkowski
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2415–2424.
Published: 01 August 2001
View article
PDF
Journal Articles

Measures of Cell Turnover (Proliferation and Apoptosis) and Their Association with Survival in Breast Cancer

Shuqing Liu, Susan M. Edgerton, Dan H. Moore, II, Ann D. Thor
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (6): 1716–1723.
Published: 01 June 2001
View article
PDF